You can buy or sell AXDX and other stocks, options, ETFs, and crypto commission-free!
Accelerate Diagnostics, Inc. Common Stock, also called Accelerate Diagnostics, is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Read More It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
52 Week High
52 Week Low
Simply Wall StMar 21
Here’s What We Think About Accelerate Diagnostics, Inc.’s (NASDAQ:AXDX) CEO Pay
Larry Mehren became the CEO of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) in 2012. First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will consider the growth in the business. And finally we will reflect on how common stockholders have fared in the last few years, as a secondary measure of performance. This process should give us an idea about how appropriately the CEO is paid. View our latest analysis for Accelerate Diagnostics How Does Larry Me...
Seeking AlphaMar 13
Accelerate Diagnostics (AXDX) Presents At Cowen and Company 39th Annual Health Care Conference - Slideshow
The following slide deck was published by Accelerate Diagnostics, Inc. in conjunction with this event. 1 22 Click to enlarge Notes:...
Simply Wall StFeb 22
If You Had Bought Accelerate Diagnostics Stock Three Years Ago, You Could Pocket A 88% Gain Today
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! By buying an index fund, investors can approximate the average market return. But if you pick the right individual stocks, you could make more than that. For example, Accelerate Diagnostics, Inc. (NASDAQ:AXDX) shareholders have seen the share price rise 88% over three years, well in excess of the market return (54%). View our latest analysis for Accelerate Diagnostics Accelerate Diagnostics is...
Expected May 9, After Hours